专家笔谈

中性粒细胞与特应性皮炎:从病理机制到研究进展

  • 唐淇钧 ,
  • 罗晓燕
展开
  • 重庆医科大学附属儿童医院皮肤科 儿童少年健康与疾病国家临床医学研究中心 儿童发育疾病研究 教育部重点实验室 儿童感染与免疫罕见病重庆市重点实验室(重庆 400014)
作者贡献(Authors’ Contributions)

唐淇钧撰写初稿并修改,罗晓燕提出修改意见并审阅最终稿。

收稿日期: 2025-12-16

  录用日期: 2026-03-23

  网络出版日期: 2026-05-08

Neutrophils and atopic dermatitis: from pathological mechanisms to research advances

  • TANG Qijun ,
  • LUO Xiaoyan
Expand
  • Department of Dermatology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immun, Chongqing 400014, China

Received date: 2025-12-16

  Accepted date: 2026-03-23

  Online published: 2026-05-08

摘要

特应性皮炎(AD)是一种由多因素介导的慢性复发性炎症性皮肤病,免疫应答异常为其核心发病机制。固有免疫细胞是AD皮肤早期炎症反应核心,并可作为关键的炎症信号传导与放大节点。中性粒细胞(NEU)作为固有免疫的核心细胞,在炎症发生和抗菌免疫中有重要作用。本文对目前 NEU 的来源、分类、活化机制及促炎、免疫抑制、非典型性等生理病理功能进行了概述,并探讨其如何在感受到皮肤炎症或抗原信号后迅速活化,随后通过趋化、脱颗粒、胞吞作用、产生活性氧和形成中性粒细胞胞外诱捕网(NETs)等效应机制促进炎症进展,招募其他免疫细胞共同参与皮肤屏障损伤以及瘙痒感觉的形成机制。本文旨在全面展示关于NEU参与AD病理生理进程的前沿观点,以帮助读者掌握这一领域的研究进展。

本文引用格式

唐淇钧 , 罗晓燕 . 中性粒细胞与特应性皮炎:从病理机制到研究进展[J]. 临床儿科杂志, 2026 , 44(5) : 405 -411 . DOI: 10.12372/jcp.2026.25e1601

Abstract

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder driven by multifactorial mechanisms, with dysregulated immune responses as its central pathogenesis. Innate immune cells serve as the core of early inflammatory reactions in AD skin and act as critical nodes for inflammatory signal transduction and amplification. Neutrophils (NEU), the pivotal cellular component of innate immunity, play essential roles in the initiation of inflammation and antibacterial immunity. This review provides an overview of the current understanding regarding the origin, classification, activation mechanisms, and physiological/pathological functions of NEU—including pro-inflammatory, immunosuppressive, and atypical properties. It further explores how NEU rapidly activate upon sensing cutaneous inflammatory or antigenic signals, and subsequently promote inflammatory progression through effector mechanisms such as chemotaxis, degranulation, phagocytosis, reactive oxygen species (ROS) production, and formation of neutrophil extracellular traps (NETs). Additionally, NEU recruit other immune cells to collectively contribute to the development of skin barrier impairment and pruritus. This review aims to comprehensively present cutting-edge insights into the involvement of NEU in the pathophysiological processes of AD, thereby facilitating readers' grasp of research advances in this field.

参考文献

[1] Sroka-Tomaszewska J, Trzeciak M. Molecular mechanisms of atopic dermatitis pathogenesis[J]. Int J Mol Sci, 2021, 22(8): 4130.
[2] Walsh CM, Hill RZ, Schwendinger-Schreck J et al. Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis[J]. Elife, 2019, 8: e48448.
[3] Zhang F, Xia Y, Su J, et al. Neutrophil diversity and function in health and disease[J]. Signal Transduct Target Ther, 2024, 9(1): 343.
[4] Riaz B, Sohn S. Neutrophils in inflammatory diseases: unraveling the impact of their derived molecules and heterogeneity[J]. Cells, 2023, 12(22): 2621.
[5] Giese MA, Hind LE, Huttenlocher A. Neutrophil plasticity in the tumor microenvironment[J]. Blood, 2019, 133(20): 2159-2167.
[6] Ng LG, Ballesteros I, Cassatella MA, et al. From complexity to consensus: a roadmap for neutrophil classification[J]. Immunity, 2025, 58(8): 1890-2903.
[7] Grieshaber-Bouyer R, Radtke FA, Cunin P, et al. The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments[J]. Nat Commun, 2021, 12(1): 2856.
[8] Parthasarathy U, Kuang Y, Thakur G, et al. Distinct subsets of neutrophils crosstalk with cytokines and metabolites in patients with sepsis[J]. iScience, 2023, 26(2): 105948.
[9] Filippi MD. Neutrophil transendothelial migration: updates and new perspectives[J]. Blood, 2019, 133(20): 2149-2158.
[10] Ballesteros I, Hidalgo A. The neutrophil collective[J]. Cell, 2025, 188(25): 7019-7035.
[11] Liew PX, Kubes P. The neutrophil's role during health and disease[J]. Physiol Rev, 2019, 99(2): 1223-1248.
[12] Siraki AG. The many roles of myeloperoxidase: from inflammation and immunity to biomarkers, drug metabolism and drug discovery[J]. Redox Biol, 2021, 46: 102109.
[13] Focken J, Scheurer J, J?ger A, et al. Neutrophil extracellular traps enhance S. aureus skin colonization by oxidative stress induction and downregulation of epidermal barrier genes[J]. Cell Rep, 2023, 42(10): 113148.
[14] Wang H, Kim SJ, Lei Y, et al. Neutrophil extracellular traps in homeostasis and disease[J]. Signal Transduct Target Ther, 2024, 9(1): 235.
[15] Tamassia N, Bianchetto-Aguilera F, Arruda-Silva F, et al. Cytokine production by human neutrophils: revisiting the "dark side of the moon"[J]. Eur J Clin Invest, 2018, 48 Suppl 2: e12952.
[16] Hahn J, Schauer C, Czegley C, et al. Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases[J]. Faseb J, 2019, 33(1): 1401-1414.
[17] Hedrick CC, Malanchi I. Neutrophils in cancer: heterogeneous and multifaceted[J]. Nat Rev Immunol, 2022, 22(3): 173-187.
[18] Morioka S, Mauer?der C, Ravichandran KS. Living on the edge: efferocytosis at the interface of homeostasis and pathology[J]. Immunity, 2019, 50(5): 1149-1162.
[19] Vicanolo T, ?zcan A, Li JL, et al. Matrix-producing neutrophils populate and shield the skin[J]. Nature, 2025, 641(8063): 740-748.
[20] Hashimoto T, Rosen JD, Sanders KM, et al. Possible role of neutrophils in itch[J]. Itch, 2018, 3(4): e17.
[21] Chung K, Pitcher T, Grant AD, et al. Cathepsin S acts via protease-activated receptor 2 to activate sensory neurons and induce itch-like behaviour[J]. Neurobiol Pain, 2019, 6: 100032.
[22] Misery L, Pierre O, Le Gall-Ianotto C, et al. Basic mechanisms of itch[J]. J Allergy Clin Immunol, 2023, 152(1): 11-23.
[23] Chen YL, Gutowska-Owsiak D, Hardman CS, et al. Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis[J]. Sci Transl Med, 2019, 11(515): eaax2945.
[24] Gouin O, L'Herondelle K, Buscaglia P, et al. Major role for TRPV1 and InsP3R in PAR2-elicited inflammatory mediator production in differentiated human keratinocytes[J]. J Invest Dermatol, 2018, 138(7): 1564-1572.
[25] Sachen KL, Arnold Greving CN, Towne JE. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions[J]. Cytokine, 2022, 156: 155897.
[26] Ahmad F, Alam MA, Ansari AW, et al. Emerging role of the IL-36/IL-36R axis in multiple inflammatory skin diseases[J]. J Invest Dermatol, 2024, 144(2): 206-224.
[27] Wang S, Song R, Wang Z, et al. S100A8/A9 in infla-mmation[J]. Front Immunol, 2018, 9: 1298.
[28] Pavlenko D, Todurga Seven Z, et al. Crisaborole inhibits itch and pain by preventing neutrophil infiltration in a mouse model of atopic dermatitis[J]. Acta Derm Venereol, 2023, 103: adv13382.
[29] Gunji Y, Matsumura T, Karasawa T, et al. IL-33-primed NLRP3 inflammasome in basophils drives IL-1β production and initiates atopic dermatitis inflammation[J]. Cell Death Discov, 2025, 11(1): 346.
[30] ?zcan A, Boyman O. Mechanisms regulating neutrophil responses in immunity, allergy, and autoimmunity[J]. Allergy, 2022, 77(12): 3567-3583.
[31] Wang X, Wang L, Wen X, et al. Interleukin-18 and IL-18BP in inflammatory dermatological diseases[J]. Front Immunol, 2023, 14: 955369.
[32] Chen JL, Niu XL, Gao YL, et al. IL-18 knockout alleviates atopic dermatitis-like skin lesions induced by MC903 in a mouse model[J]. Int J Mol Med, 2020, 46(2): 880-888.
[33] Aroca-Crevillén A, Vicanolo T, Ovadia S, et al. Neutrophils in physiology and pathology[J]. Annu Rev Pathol, 2024, 19: 227-259.
[34] Chiang CC, Cheng WJ, Dela Cruz JRMS, et al. Neutrophils in atopic dermatitis[J]. Clin Rev Allergy Immunol, 2024, 67(1-3): 21-39.
[35] Kvedariene V, Vaskovic M, Semyte JB. Role of oxidative stress and antioxidants in the course of atopic dermatitis[J]. Int J Mol Sci, 2025, 26(9): 4210.
[36] Aarts CEM, Hiemstra IH, Béguin EP et al. Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair[J]. Blood Adv, 2019, 3(22): 3562-3574.
[37] Tong X, Kim SH, Che L, et al. Foxp3(+) Treg control allergic skin inflammation by restricting IFN-γ-driven neutrophilic infiltration and NETosis [J]. J Dermatol Sci, 2024, 115(1): 2-12.
[38] Liao TL, Lin CC, Chen YH, et al. Reduced miR-223 increases blood neutrophil extracellular trap and promotes skin inflammation in atopic dermatitis[J]. Allergy, 2023, 78(12): 3252-3254.
[39] Kline SN, Feller LE, Saito Y, et al. Epicutaneous staphylococcus aureus initiates cross-tissue IL-36R signaling for neutrophilic lung inflammation in a model of the atopic march[J]. Cell Rep, 2025, 44(8): 116054.
[40] Mali SS, Bautista DM. Basophils add fuel to the flame of eczema itch[J]. Cell, 2021, 184(2): 294-296.
[41] Dudeck J, Kotrba J, Immler R, et al. Directional mast cell degranulation of tumor necrosis factor into blood vessels primes neutrophil extravasation[J]. Immunity, 2021, 54(3): 468-483.
[42] Mihlan M, Wissmann S, Gavrilov A, et al. Neutrophil trapping and nexocytosis, mast cell-mediated processes for inflammatory signal relay[J]. Cell, 2024, 187(19): 5316-5335.
[43] Zheng C, Cao T, Ye C, et al. Neutrophil recruitment by CD4 tissue-resident memory T cells induces chronic recurrent inflammation in atopic dermatitis[J]. Clin Immunol, 2023, 256: 109805.
[44] 陈星宇, 姚煦. 中性粒细胞在过敏和自身免疫中的调节机制[J]. 中华临床免疫和变态反应杂志, 2022, 16(5): 550-551.
  Chen XY, Yao X. Neutrophil programmed cell death in the pathogenesis of Beh?et's disease[J]. Zhonghua Linchuang Mianyi He Biantaifanying Zazhi, 16(5): 550-551.
[45] Egholm C, ?zcan A, Breu D, et al. Type 2 immune predisposition results in accelerated neutrophil aging causing susceptibility to bacterial infection[J]. Sci Immunol, 2022, 7(71): eabi9733.
文章导航

/